These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37173801)

  • 1. The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer's disease: a natural language processing study.
    Eikelboom WS; Singleton EH; van den Berg E; de Boer C; Coesmans M; Goudzwaard JA; Vijverberg EGB; Pan M; Gouw C; Mol MO; Gillissen F; Fieldhouse JLP; Pijnenburg YAL; van der Flier WM; van Swieten JC; Ossenkoppele R; Kors JA; Papma JM
    Alzheimers Res Ther; 2023 May; 15(1):94. PubMed ID: 37173801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    Fonseca LM; Mattar GP; Haddad GG; Burduli E; McPherson SM; Guilhoto LMFF; Yassuda MS; Busatto GF; Bottino CMC; Hoexter MQ; Chaytor NS
    J Alzheimers Dis; 2021; 81(1):137-154. PubMed ID: 33749644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis.
    Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
    J Affect Disord; 2016 Jan; 190():264-271. PubMed ID: 26540080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.
    Gonfrier S; Andrieu S; Renaud D; Vellas B; Robert PH
    J Nutr Health Aging; 2012 Feb; 16(2):134-7. PubMed ID: 22323347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.
    García-Martín V; de Hoyos-Alonso MC; Ariza-Cardiel G; Delgado-Puebla R; García-Domingo P; Hernández-Melo E; de Haro-de Torres JL; Del Cura-González I
    BMC Geriatr; 2022 Jan; 22(1):71. PubMed ID: 35065615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.
    Honjo Y; Ide K; Takechi H
    Psychogeriatrics; 2022 May; 22(3):317-323. PubMed ID: 35146847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assess the documentation of cognitive tests and biomarkers in electronic health records via natural language processing for Alzheimer's disease and related dementias.
    Chen Z; Zhang H; Yang X; Wu S; He X; Xu J; Guo J; Prosperi M; Wang F; Xu H; Chen Y; Hu H; DeKosky ST; Farrer M; Guo Y; Wu Y; Bian J
    Int J Med Inform; 2023 Feb; 170():104973. PubMed ID: 36577203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between neuropsychiatric symptoms and cognitive functions in patients with cognitive impairment.
    Lü W; Duan J; Zhang W; Yang W; Yu W
    Psychogeriatrics; 2021 Sep; 21(5):773-782. PubMed ID: 34216181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
    J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of affective states on informant impression of neuropsychiatric symptoms in people living with MCI.
    Therrien S; Turnbull A; Anthony M; Conwell Y; Lin FV
    Aging Ment Health; 2023; 27(11):2128-2133. PubMed ID: 36995269
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.